<?xml version="1.0" encoding="UTF-8"?>
<p>The ambivalence and reluctance that were expressed by some of the study participants–the initial rumors that participants would be harmed in the study and that blood would be sold or used during political campaigning–revealed concerns that were present before the actual study process started and when informational meetings with key stakeholders were held. These rumors are indicative of the atmosphere in which the study was started, and, as mentioned above, the mistrust that was felt towards everything that had to do with “Ebola”. On a deeper level, these rumors may have been expressions of broader societal challenges and historical circumstances. They may have revealed uncertainties of who would really profit from the sampling of the body fluids, an issue that is broadly discussed within the scientific community as well. Ethical considerations of biobanking, especially in the context of disease outbreaks and under conditions of socioeconomic inequities, are hotly debated and the ethical adequacy of material transfer questioned [
 <xref rid="pntd.0008327.ref027" ref-type="bibr">27</xref>]. The ownership of samples collected during the West African EVD outbreak is still unclear and an inventory on the location of samples lacking [
 <xref rid="pntd.0008327.ref028" ref-type="bibr">28</xref>].
</p>
